Biocytogen Overview

  • Founded
  • 2008
Founded
  • Status
  • Private
  • Employees
  • 68
Employees
  • Latest Deal Type
  • Series D1
  • Latest Deal Amount
  • $142M
Latest Deal Amount
  • Investors
  • 11

Biocytogen General Information

Description

Operator of a preclinical stage biotech company intended to transform antibody discovery with the help of innovative models. The company develops an integrated platform for efficient antibody drug discovery by utilizing gene-editing technologies, thus providing pharmaceutical and biotech startups with preclinical services, animal model generation, therapeutic antibody discoveries, and development services.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Delivery
Other Industries
Laboratory Services (Healthcare)
Biotechnology
Primary Office
  • 50C Audubon Road
  • Wakefield, MA 01880
  • United States
+1 (781) 000-0000

Biocytogen Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Biocytogen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series D1) 15-Sep-2020 $142M 00000 Completed Generating Revenue
5. Later Stage VC (Series D) 08-Aug-2019 000.00 00000 Completed Generating Revenue
4. Later Stage VC (Series C) 10-Apr-2018 0000 000.00 Completed Generating Revenue
3. Later Stage VC (Series B) 01-Oct-2015 00.00 Completed Generating Revenue
2. Later Stage VC (Series A) 19-Aug-2013 $5.6M $5.6M Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view Biocytogen’s complete valuation and funding history, request access »

Biocytogen Executive Team (3)

Name Title Board Seat Contact Info
Yuelei Shen Ph.D Founder, Chief Executive Officer, President & Chairman
Benny Yang Ph.D Chief Scientific Officer & Director of Antibody Discovery
Chaoshe Guo Ph.D Vice President & Global Head of Business Development
To view Biocytogen’s complete executive team members history, request access »

Biocytogen Board Members (2)

Name Representing Role Since
Bing Zhuo BVCF Board Member 000 0000
Yuelei Shen Ph.D Biocytogen Founder, Chief Executive Officer, President & Chairman 000 0000
To view Biocytogen’s complete board members history, request access »

Biocytogen Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biocytogen Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Baifuyuan Capital Venture Capital Minority 000 0000 000000 0
China Life Private Equity Growth/Expansion Minority 000 0000 000000 0
PICC Capital Investment Management PE/Buyout Minority 000 0000 000000 0
China Life Investment Holding Company Asset Manager Minority 000 0000 000000 0
3E Bioventures Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »

Biocytogen Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 0000000000 28-Sep-2020 00000 00000 00 00.000 Biotechnology
Eucure Biopharma 24-Sep-2020 Merger/Acquisition Drug Discovery
To view Biocytogen’s complete investments and acquisitions history, request access »